Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00834600 · ClinicalTrials.gov registry record · NA

Renin Profiling in Selection of Initial Antihypertensive Drug

A NA study of Hypertension, sponsored by The Louis & Rachel Rudin Foundation.

Completed
Registry status
NA
Development phase
185
Enrollment target
5
Study locations

NCT00834600: Completed NA study of Hypertension, sponsored by The Louis & Rachel Rudin Foundation.

NCT00834600 is a NA study of Hypertension that has completed, run by The Louis & Rachel Rudin Foundation. The registered enrollment target is 185 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00834600, a NA study of Hypertension, has completed, sponsored by The Louis & Rachel Rudin Foundation.

COMPLETED
Registry status
NA
Development phase
185 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this research study is to determine whether a simple blood test measuring a hormone called renin can better determine which first drug would be most effective in controlling blood pressure, in comparison with the more traditional approach recommended by JNC7 (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure).

Conditions Studied

Interventions

  • DRUG olmesartan, hydrochlorothiazide, amlodipine
  • DRUG hydrochlorothiazide (HCTZ) or olmesartan

Study Locations (5)

New York

  • Lincoln Medical and Mental Health Center - The Bronx
  • Albert Einstein College of Medicine - GCRC - The Bronx
  • Jacobi Medical Center - The Bronx
  • Bronx Nephrology Hypertension, PC - The Bronx
  • Ralph Yung, MD - The Bronx

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2005-12
Est. Completion 2011-10
Phase NA

What the Registry Record Tells You About NCT00834600

The ClinicalTrials.gov registry entry for NCT00834600 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The listed sponsor is The Louis & Rachel Rudin Foundation, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which olmesartan, hydrochlorothiazide, amlodipine is the first listed.

NCT00834600 reports 5 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00834600 about?

NCT00834600 is a clinical study titled "Renin Profiling in Selection of Initial Antihypertensive Drug". The purpose of this research study is to determine whether a simple blood test measuring a hormone called renin can better determine which first drug would be most effective in controlling blood pressure, in comparison with the more traditional approach recommended by JNC7 (Joint National Committee ...

What is the current status of trial NCT00834600?

This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2005-12. Estimated completion is 2011-10.

What conditions does trial NCT00834600 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00834600?

The interventions under investigation include: olmesartan, hydrochlorothiazide, amlodipine (DRUG), hydrochlorothiazide (HCTZ) or olmesartan (DRUG).

Who is sponsoring clinical trial NCT00834600?

This trial is sponsored by The Louis & Rachel Rudin Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00834600 being conducted?

This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.